CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
87 hedge funds and large institutions have $202M invested in Concert Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-5
Holders Change %
-5.43%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
35
Reduced
21
Closed
23
Calls
$3.21M
Puts
$2.92M
Net Calls
+$293K
Net Calls Change
-$714K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$9.15M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
$5.52M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
$19.5M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
$4.23M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
$16.3M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
$0 |
| 2 |
First Manhattan
New York
|
$0 |
| 3 |
Millennium Management
New York
|
$6.3M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
$4.09M |
| 5 |
Renaissance Technologies
New York
|
$7.39M |
